Bertalmio A J, Herling S, Hampton R Y, Winger G, Woods J H
J Pharmacol Methods. 1982 Jun;7(4):289-99. doi: 10.1016/0160-5402(82)90082-1.
Rhesus monkeys were trained in a two-lever drug-discrimination procedure with several discrete trials per session. During training sessions, either a sham injection or a subcutaneous injection of the training drug was administered ten minutes prior to each trial. During each trial, completion of 100 consecutive responses on the lever appropriate for the animal's pharmacological condition (e.g., left for sham, right for drug) resulted in the delivery of three grams of food. Training sessions consisted of from zero to four sham trials that preceded two consecutive drug trials. The number of sham trials varied unsystematically to preclude discrimination of the drug trials on the basis of the number of preceding trials. Discriminations were established with each of the training drugs employed (codeine, methohexital, and ketamine). During dose-effect evaluations of the training drug or other drugs (test sessions), a progressively large dose of drug was injected prior to each trial and 100 consecutive responses on either the sham- or drug-appropriate lever resulted in the delivery of food. Test sessions continued until either drug-lever responding or a marked suppression in the rate of responding occurred. Thus, a cumulative dose-effect curve for each drug was generated within a single session. Preliminary findings suggest that the pattern of cross-drug generalization generated by this cumulative-dosing procedure is similar to that obtained with procedures that evaluate only a single dose of drug per session.
恒河猴接受了双杠杆药物辨别程序的训练,每次训练有若干次独立试验。在训练期间,每次试验前10分钟,要么进行假注射,要么皮下注射训练药物。在每次试验中,在与动物药理状态相适应的杠杆(例如,假注射时为左杠杆,药物注射时为右杠杆)上连续完成100次反应,会得到3克食物。训练包括在两次连续的药物试验之前进行零至四次假试验。假试验的次数无规律变化,以防止根据之前试验的次数来辨别药物试验。使用的每种训练药物(可待因、美索比妥和氯胺酮)都建立了辨别能力。在对训练药物或其他药物进行剂量效应评估时(测试阶段),每次试验前注射逐渐增大剂量的药物,在与假注射或药物相适应的杠杆上连续100次反应会得到食物。测试阶段持续进行,直到出现药物杠杆反应或反应速率明显抑制。因此,在单个测试阶段内生成了每种药物的累积剂量效应曲线。初步研究结果表明,这种累积给药程序产生的交叉药物泛化模式与每次测试阶段仅评估单一剂量药物的程序所获得的模式相似。